Equities

Tonghua Dongbao Pharmaceutical Co Ltd

600867:SHH

Tonghua Dongbao Pharmaceutical Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (CNY)7.21
  • Today's Change0.01 / 0.14%
  • Shares traded8.55m
  • 1 Year change-31.59%
  • Beta0.4722
Data delayed at least 15 minutes, as of Sep 13 2024 08:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of CNY
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments1,160847902
Total Receivables, Net917511673
Total Inventory705654538
Prepaid expenses344550
Other current assets, total------
Total current assets2,8162,0562,162
Property, plant & equipment, net2,7042,7452,603
Goodwill, net------
Intangibles, net1,3381,069797
Long term investments534458557
Note receivable - long term------
Other long term assets------
Total assets7,7716,7506,520
LIABILITIES
Accounts payable1168175
Accrued expenses311232
Notes payable/short-term debt15000
Current portion long-term debt/capital leases------
Other current liabilities, total22370162
Total current liabilities520162269
Total long term debt000
Total debt15000
Deferred income tax7.417.51--
Minority interest5.095.315.35
Other liabilities, total283131
Total liabilities560206305
SHAREHOLDERS EQUITY
Common stock1,9941,9942,034
Additional paid-in capital6236421,006
Retained earnings (accumulated deficit)4,7254,0533,567
Treasury stock - common(135)(150)(398)
Unrealized gain (loss)------
Other equity, total5.286.396.94
Total equity7,2116,5446,215
Total liabilities & shareholders' equity7,7716,7506,520
Total common shares outstanding1,9921,9912,008
Treasury shares - common primary issue1.163.1126
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.